Assessment of SLEDAI score changes in systemic lupus erythematosus patients under low-dose interleukin-2 therapy: A meta-analysis

Background: Interleukin-2 is being investigated as a potential therapeutic option in systemic lupus erythematosus (SLE), but the current findings regarding its effectiveness remained inconclusive. Objectives: To assess the association between the administration of low-dose interleukin-2 and the SLE...

Cijeli opis

Bibliografski detalji

Glavni autori:	Dwi Soelistyoningsih, Hani Susianti, Handono Kalim, Kusworini Handono, Jonny Karunia Fajar
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2024-09-01
Serija:	Clinical Epidemiology and Global Health
Teme:	Systemic lupus erythematosus SLE disease activity index Interleukin-2 Treatment Prognosis
Online pristup:	http://www.sciencedirect.com/science/article/pii/S2213398424002008
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!